跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Approved
THERAPEUTIC
HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Qilu Pharmaceutical (Hainan) Co. Ltd
🇸🇬 Health Sciences Authority
Approval Date
Mar 16, 2020
Approval ID
5720005613933101
Company
Qilu Pharmaceutical (Hainan) Co. Ltd
Type
Therapeutic
Approval Details
Approval Id
5720005613933101
Drug Name
HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Product Name
HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Approval Number
SIN15910P
Approval Date
2020-03-16
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01XA03
Atc Item Name
oxaliplatin
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
Oxaliplatin
50 mg/vial
OXALIPLATIN
50 MG/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 16, 2020
Approval ID
5720005613933101
Type
Therapeutic
Back to HSA Approvals
HOVID OXALIPLATIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL - HSA Drug Approval Details
